These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 1963067)
1. [Treatment of supratentorial glioma with intracarotid cisplatin and intravenous carmustine]. Rebollo J; Martín-Algarra S; Bilbao I; Zubieta JL; Calvo FA; de Castro P; Pastor MA; Viteri C; Martínez Lage JM Neurologia; 1990; 5(7):228-32. PubMed ID: 1963067 [TBL] [Abstract][Full Text] [Related]
2. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients. Fernández-Hidalgo OA; Vanaclocha V; Vieitez JM; Aristu JJ; Rebollo J; Gúrpide A; Aramendía JM; Moreno-Palanques R; Martín-Algarra S; Subirá ML; Brugarolas A Bone Marrow Transplant; 1996 Jul; 18(1):143-9. PubMed ID: 8832007 [TBL] [Abstract][Full Text] [Related]
3. A sequential chemo-radiotherapeutic treatment for patients with malignant gliomas: a phase II pilot study. Dazzi C; Cariello A; Giannini M; Del Duca M; Giovanis P; Fiorentini G; Leoni M; Rosti G; Turci D; Tienghi A; Vertogen B; Zumaglini F; De Giorgi U; Marangolo M Anticancer Res; 2000; 20(1B):515-8. PubMed ID: 10769716 [TBL] [Abstract][Full Text] [Related]
4. BCNU-DBD (Dibromodulcitol) chemotherapy of recurrent supratentorial anaplastic astrocytomas and glioblastomas. Vitanovics D; Sipos L; Afra D Neoplasma; 2002; 49(5):342-5. PubMed ID: 12458335 [TBL] [Abstract][Full Text] [Related]
5. [Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma]. Linassier C; Destrieux C; Benboubker L; Alcaraz L; Bergemer-Fouquet AM; Jan M; Calais G; Colombat P Bull Cancer; 2001 Sep; 88(9):871-6. PubMed ID: 11604360 [TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study. Watanabe K; Kanaya H; Fujiyama Y; Kim P Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337 [TBL] [Abstract][Full Text] [Related]
7. Phase II trial of carmustine, cisplatin, and oral etoposide chemotherapy before radiotherapy for grade 3 astrocytoma (anaplastic astrocytoma): results of North Central Cancer Treatment Group trial 98-72-51. Rao RD; Krishnan S; Fitch TR; Schomberg PJ; Dinapoli RP; Nordstrom K; Scheithauer B; O'Fallon JR; Maurer MJ; Buckner JC Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):380-6. PubMed ID: 15667956 [TBL] [Abstract][Full Text] [Related]
8. Treatment of recurrent brain tumors with intra-arterial cis-platinum and BCNU. Kapp JP; Vance R J Miss State Med Assoc; 1984 Jan; 25(1):1-6. PubMed ID: 6325705 [No Abstract] [Full Text] [Related]
9. Radiochemotherapy of malignant glioma in adults. Clinical experiences. Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711 [TBL] [Abstract][Full Text] [Related]
10. Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394. Grossman SA; O'Neill A; Grunnet M; Mehta M; Pearlman JL; Wagner H; Gilbert M; Newton HB; Hellman R; J Clin Oncol; 2003 Apr; 21(8):1485-91. PubMed ID: 12697871 [TBL] [Abstract][Full Text] [Related]
12. [Combined treatment of glyal and metastatic tumors of the brain]. Fadeev BP; Zhabina RM Vestn Khir Im I I Grek; 2005; 164(1):80-2. PubMed ID: 15957817 [TBL] [Abstract][Full Text] [Related]
13. Preirradiation chemotherapy of supratentorial malignant primary brain tumors with intracarotid cis-platinum (CDDP) and i.v. BCNU. A phase II trial. Recht L; Fram RJ; Strauss G; Fitzgerald TJ; Liepman M; Lew R; Kadish S; Sherman D; Wilson J; Greenberger J Am J Clin Oncol; 1990 Apr; 13(2):125-31. PubMed ID: 2156417 [TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)]. Afra D; Sipos L; Vitanovics D Ideggyogy Sz; 2002 Jan; 55(1-2):38-44. PubMed ID: 12122942 [TBL] [Abstract][Full Text] [Related]
15. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients. Durando X; Lemaire JJ; Tortochaux J; Van-Praagh I; Kwiatkowski F; Vincent C; Bailly C; Verrelle P; Irthum B; Chazal J; Bay JO Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621 [TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy protocol "8 drugs in 1 day" in patients with recurrent malignant glioma]. Jeremić B; Grujicić D; Matović M Srp Arh Celok Lek; 1994; 122(3-4):73-5. PubMed ID: 17972813 [TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of malignant gliomas: studies of the BTCG. Shapiro WR Rev Neurol (Paris); 1992; 148(6-7):428-34. PubMed ID: 1448662 [TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy with carmustine and cisplatin followed by procarbazine, lomustine, and vincristine for adult high-grade astrocytoma. Liau CT; Wei KC; Tseng CK; Jung SM Chang Gung Med J; 2005 Jan; 28(1):16-23. PubMed ID: 15804144 [TBL] [Abstract][Full Text] [Related]
19. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials. Buckner JC; Ballman KV; Michalak JC; Burton GV; Cascino TL; Schomberg PJ; Hawkins RB; Scheithauer BW; Sandler HM; Marks RS; O'Fallon JR; ; J Clin Oncol; 2006 Aug; 24(24):3871-9. PubMed ID: 16921039 [TBL] [Abstract][Full Text] [Related]
20. Phase II evaluation of infusional etoposide and cisplatin in patients with recurrent astrocytoma. Buckner JC; Brown LD; Cascino TL; Gerstner JB; Krook JE; Westberg MW; Wiesenfeld M; O'Fallon JR; Scheithauer B J Neurooncol; 1990 Dec; 9(3):249-54. PubMed ID: 2086739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]